Hamilton Beach Brands Holding Co — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Hamilton Beach Brands Holding Co filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $606.85M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $654.69M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $625.63M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $640.95M | Feb 26, 2025 |
| FY2020 | Dec 31, 2020 | $234.02M | Mar 22, 2021 |
| FY2020 | Sep 30, 2020 | $110.55M | Mar 22, 2021 |
| FY2020 | Jun 30, 2020 | $138.30M | Mar 22, 2021 |
| FY2020 | Mar 31, 2020 | $120.85M | Mar 22, 2021 |
| FY2020 | Dec 31, 2019 | $204.57M | Mar 22, 2021 |
| FY2020 | Sep 30, 2019 | $149.51M | Mar 22, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $625.63M | Mar 6, 2024 |
| FY2023 | Dec 31, 2022 | $640.95M | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | $658.39M | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $603.71M | Mar 9, 2023 |
| FY2019 | Dec 31, 2019 | $204.57M | Jul 24, 2020 |
| FY2019 | Sep 30, 2019 | $149.51M | Jul 24, 2020 |
| FY2019 | Jun 30, 2019 | $131.07M | Jul 24, 2020 |
| FY2019 | Mar 31, 2019 | $126.64M | Jul 24, 2020 |
| FY2019 | Dec 31, 2018 | $198.17M | Jul 24, 2020 |
| FY2019 | Sep 30, 2018 | $171.30M | Jul 24, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $156.15M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $170.21M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $143.68M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $129.11M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $136.50M | Mar 6, 2024 |
| FY2020 | Dec 31, 2020 | $54.61M | Mar 22, 2021 |
| FY2020 | Sep 30, 2020 | $23.75M | Mar 22, 2021 |
| FY2020 | Jun 30, 2020 | $35.25M | Mar 22, 2021 |
| FY2020 | Mar 31, 2020 | $25.04M | Mar 22, 2021 |
| FY2020 | Dec 31, 2019 | $42.40M | Mar 22, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.46M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $30.76M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $25.24M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $25.27M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $21.31M | Mar 6, 2024 |
| FY2020 | Dec 31, 2020 | $19.00M | Mar 22, 2021 |
| FY2020 | Sep 30, 2020 | ($2.01M) | Mar 22, 2021 |
| FY2020 | Jun 30, 2020 | $7.76M | Mar 22, 2021 |
| FY2020 | Mar 31, 2020 | $21.51M | Mar 22, 2021 |
| FY2020 | Dec 31, 2019 | ($7.30M) | Mar 22, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.58M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $43.20M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $35.08M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $38.79M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $31.54M | Mar 6, 2024 |
| FY2020 | Dec 31, 2020 | $28.42M | Mar 22, 2021 |
| FY2020 | Sep 30, 2020 | ($2.41M) | Mar 22, 2021 |
| FY2020 | Jun 30, 2020 | $10.90M | Mar 22, 2021 |
| FY2020 | Mar 31, 2020 | $503.0K | Mar 22, 2021 |
| FY2020 | Dec 31, 2019 | $19.06M | Mar 22, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.20M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $13.70M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $12.40M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $11.80M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $8.60M | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $10.00M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $12.10M | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | $11.00M | Mar 22, 2021 |
| FY2019 | Dec 31, 2017 | $10.40M | Jul 24, 2020 |
| FY2018 | Dec 31, 2016 | $9.70M | Mar 6, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $119.26M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $126.70M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $108.40M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $90.12M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $104.76M | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $99.99M | Mar 9, 2023 |
| FY2019 | Dec 31, 2019 | $23.00M | Jul 24, 2020 |
| FY2019 | Sep 30, 2019 | $26.17M | Jul 24, 2020 |
| FY2019 | Jun 30, 2019 | $24.98M | Jul 24, 2020 |
| FY2019 | Mar 31, 2019 | $26.25M | Jul 24, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.81M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $65.42M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $88.64M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($3.42M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $17.86M | Mar 6, 2024 |
| FY2018 | Dec 31, 2018 | $11.82M | Mar 6, 2019 |
| FY2018 | Dec 31, 2017 | $33.44M | Mar 6, 2019 |
| FY2018 | Dec 31, 2016 | $62.56M | Mar 6, 2019 |
| FY2017 | Dec 31, 2015 | $26.49M | Mar 7, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.78M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3.19M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $3.42M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $2.28M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $11.84M | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $3.31M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $4.12M | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | $7.76M | Mar 22, 2021 |
| FY2019 | Dec 31, 2017 | $6.20M | Jul 24, 2020 |
| FY2018 | Dec 31, 2016 | $6.00M | Mar 6, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $397.62M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $415.07M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $384.70M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $388.95M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $382.50M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $391.17M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $288.66M | Mar 22, 2021 |
| FY2019 | Sep 30, 2019 | $352.28M | Jul 24, 2020 |
| FY2019 | Jun 30, 2019 | $296.89M | Jul 24, 2020 |
| FY2019 | Mar 31, 2019 | $293.26M | Jul 24, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $214.78M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $249.16M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $237.44M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $264.42M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $280.23M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $311.06M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $252.40M | Mar 22, 2021 |
| FY2019 | Sep 30, 2019 | $309.74M | Jul 24, 2020 |
| FY2019 | Jun 30, 2019 | $247.70M | Jul 24, 2020 |
| FY2019 | Mar 31, 2019 | $240.30M | Jul 24, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $182.85M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $165.90M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $147.27M | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | $124.53M | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | $102.28M | Feb 26, 2025 |
| FY2023 | Dec 31, 2020 | $80.11M | Mar 6, 2024 |
| FY2022 | Dec 31, 2019 | $36.27M | Mar 9, 2023 |
| FY2019 | Sep 30, 2019 | $42.54M | Jul 24, 2020 |
| FY2019 | Jun 30, 2019 | $49.19M | Jul 24, 2020 |
| FY2019 | Mar 31, 2019 | $52.96M | Jul 24, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.10M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $7.10M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $6.25M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $6.25M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $6.25M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $6.25M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $6.25M | Mar 22, 2021 |
| FY2019 | Sep 30, 2019 | $6.25M | Jul 24, 2020 |
| FY2019 | Jun 30, 2019 | $6.25M | Jul 24, 2020 |
| FY2019 | Mar 31, 2019 | $6.25M | Jul 24, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $143.89M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $123.86M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $99.40M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $80.24M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $60.75M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $44.92M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $3.71M | Mar 22, 2021 |
| FY2019 | Sep 30, 2019 | $12.23M | Jul 24, 2020 |
| FY2019 | Jun 30, 2019 | $15.65M | Jul 24, 2020 |
| FY2019 | Mar 31, 2019 | $17.51M | Jul 24, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.31M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $45.64M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $15.37M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $928.0K | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $1.13M | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $2.42M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $2.14M | Mar 9, 2022 |
| FY2019 | Sep 30, 2019 | $1.56M | Jul 24, 2020 |
| FY2019 | Jun 30, 2019 | $1.03M | Jul 24, 2020 |
| FY2019 | Mar 31, 2019 | $1.64M | Jul 24, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $50.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $50.00M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $110.90M | Mar 6, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 6, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Mar 22, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 22, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 22, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Mar 22, 2021 |
| FY2019 | Dec 31, 2019 | 0 | Jul 24, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 6, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Mar 22, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 22, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 22, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Mar 22, 2021 |
| FY2021 | Dec 31, 2019 | 0 | Mar 9, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2016 | 100 | Mar 7, 2018 |